Document

0001628280-22-009599.txt : 20220420 0001628280-22-009599.hdr.sgml : 20220420 20220420091714 ACCESSION NUMBER: 0001628280-22-009599 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220420 FILED AS OF DATE: 20220420 DATE AS OF CHANGE: 20220420 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MorphoSys AG CENTRAL INDEX KEY: 0001340243 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38455 FILM NUMBER: 22836440 BUSINESS ADDRESS: STREET 1: SEMMELWEISSTR. 7 CITY: PLANEGG STATE: 2M ZIP: 82152 BUSINESS PHONE: 49 89 89927-0 MAIL ADDRESS: STREET 1: SEMMELWEISSTR. 7 CITY: PLANEGG STATE: 2M ZIP: 82152 FORMER COMPANY: FORMER CONFORMED NAME: MORPHOSYS AG DATE OF NAME CHANGE: 20050929 6-K 1 a220420_6-kxmordirectordea.htm 6-K Document

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549
______________________

FORM 6-K

REPORT OF A FOREIGN ISSUER

PURSUANT TO RULE 13A-16 OR 15D-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For April 20, 2022

_______________Commission File Number 1-38455_______

MorphoSys AG

Semmelweisstrasse 7

82152 Planegg

Germany

(Address of principal executive offices)

______________________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒ Form 40-F ☐

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ☐ No ☒

If ‘‘Yes’’ is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b):

Exhibits

99.1 Notification of managers`transactions according to article 19 MAR

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

MORPHOSYS AG (Registrant)

Date: April 20, 2022 By: /s/ i.A. Isabelle Degbegni

Name: Isabelle Degbegni

Title: Director Investor Relations

By: /s/ i.A. Kristina Grötsch

Name: Kristina Grötsch

Title: Senior Specialist Investor Relations

EX-99.1 2 a220420_exhibit991.htm EX-99.1 Document

Notification of managers`transactions according to article 19 MAR


1	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Dr. Malte Peters
2	Reason for the notification
a)	Position/status	Member of the managing body
b)	Initial notification/Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	MorphoSys AG
b)	LEI	529900493806K77LRE72
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument. type of instrument Identification code	Shares of MorphoSys AG, ISIN DE0006632003
b)	Nature of the transaction	Allocation of 1,070 shares as part of his remuneration as member of the Managing Board (Performance Share Plan 2018) (issuer's own shares)
c)	Price(s) and volume(s)	Price Volume Not numerable Not numerable
d)	Aggregated information Aggregated volume Price
e)	Date of the transaction	2022-04-20; UTC+2
f)	Place of the transaction	Outside a trading venue